AWA
TXG icon

Aaron Wealth Advisors’s 10x Genomics TXG Stock Holding History

Aaron Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
48,221
+1,840
+4% +$48.2K 0.09% 137
2026
Q1 		$985K Sell
46,381
-20,033
-30% -$400K 0.06% 229
2025
Q4 		$1.08M Buy
66,414
+26,884
+68% +$406K 0.06% 232
2025
Q3 		$462K Buy
+39,530
New +$515K 0.03% 432

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aaron Wealth Advisors's TXG Position: Q2 2026 in Review

Aaron Wealth Advisors increased its 10x Genomics (TXG) stake by 4% in Q2 2026, buying an estimated $48.2K and bringing the position to 48,221 shares worth $1.85M. The position accounts for 0.09% of the portfolio, ranked #137.

Aaron Wealth Advisors first reported a position in TXG in Q3 2025 and has held it in 4 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Aaron Wealth Advisors held 48,221 shares of 10x Genomics worth $1.85M as of Q2 2026.
  • Aaron Wealth Advisors bought 1,840 10x Genomics shares in Q2 2026, an estimated $48.2K.
  • 10x Genomics made up 0.09% of Aaron Wealth Advisors's portfolio in Q2 2026, its #137 holding.
  • Aaron Wealth Advisors first reported a position in 10x Genomics in Q3 2025 and has held it in 4 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.